These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25669106)

  • 21. Relations between open-field, elevated plus-maze, and emergence tests in C57BL/6J and BALB/c mice injected with GABA- and 5HT-anxiolytic agents.
    Lalonde R; Strazielle C
    Fundam Clin Pharmacol; 2010 Jun; 24(3):365-76. PubMed ID: 19735300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents.
    Alfredo BA; Ofir P
    Eur J Pharmacol; 2005 Jan; 508(1-3):155-8. PubMed ID: 15680266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal Stimulation of 5-HT
    Mikhailenko VA; Butkevich IP
    Bull Exp Biol Med; 2019 Jan; 166(3):306-309. PubMed ID: 30656521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression.
    Rhoads DE; Grimes N; Kaushal S; Mallari J; Orlando K
    Pharmacol Biochem Behav; 2012 Jul; 102(1):58-63. PubMed ID: 22494991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study.
    Watanabe A; Hasegawa S; Nishi K; Nguyen KQ; Diksic M
    Brain Res Bull; 2006 Mar; 69(2):101-8. PubMed ID: 16533657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.
    Pokorny T; Preller KH; Kraehenmann R; Vollenweider FX
    Eur Neuropsychopharmacol; 2016 Apr; 26(4):756-66. PubMed ID: 26875114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuation of methylphenidate-induced sensitization by co-administration of buspirone.
    Alam N; Najam R; Naeem S
    Pak J Pharm Sci; 2016 Mar; 29(2):585-90. PubMed ID: 27087081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harm avoidance, anxiety, and response to novelty in the adolescent S-100beta transgenic mouse: role of serotonin and relevance to Down syndrome.
    Bell K; Shokrian D; Potenzieri C; Whitaker-Azmitia PM
    Neuropsychopharmacology; 2003 Oct; 28(10):1810-6. PubMed ID: 12888777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety.
    Brunelli SA; Aviles JA; Gannon KS; Branscomb A; Shacham S
    Pharmacol Biochem Behav; 2009 Nov; 94(1):8-15. PubMed ID: 19576924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Behavioral effects of m-CPP and ketanserine during ovarian cycle in female rats].
    Fedotova IuO
    Eksp Klin Farmakol; 2010 Nov; 73(11):6-9. PubMed ID: 21254590
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The anxiolytic buspirone shifts coping strategy in novel environmental context of mice with different anxious phenotype.
    Horváth J; Szögi T; Müller G; Szegedi V
    Behav Brain Res; 2013 Aug; 250():32-8. PubMed ID: 23608485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder.
    Malikowska-Racia N; Popik P; Sałat K
    Behav Brain Res; 2020 Mar; 381():112380. PubMed ID: 31765726
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of glucocorticoids on the anxiolytic efficacy of buspirone.
    Haller J; Leveleki C; Halász J; Baranyi J; Makara GB
    Psychopharmacology (Berl); 2001 Oct; 157(4):388-94. PubMed ID: 11605098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice.
    Briones-Aranda A; López-Rubalcava C; Picazo O
    Psychopharmacology (Berl); 2002 Jul; 162(2):147-55. PubMed ID: 12110992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A possible mechanism for the anxiolytic-like effect of gallic acid in the rat elevated plus maze.
    Mansouri MT; Soltani M; Naghizadeh B; Farbood Y; Mashak A; Sarkaki A
    Pharmacol Biochem Behav; 2014 Feb; 117():40-6. PubMed ID: 24345572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice.
    Sugimoto Y; Takashima N; Noma T; Yamada J
    J Pharmacol Sci; 2003 Dec; 93(4):446-50. PubMed ID: 14737015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Behavioral effects of ketanserine in prenatally stressed female rats].
    Fedotova IuO; Pivina SG; Ordian NE
    Eksp Klin Farmakol; 2012; 75(1):12-5. PubMed ID: 22442956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute and subchronic effects of buspirone on attention and impulsivity in the five-choice serial reaction time task in rats.
    Lu CL; Ku YC; Lo SM; Peng CH; Tung CS; Lin YW; Liu YP
    Neurosci Lett; 2013 Nov; 556():210-5. PubMed ID: 24135334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular basis of buspirone's anxiolytic action.
    Tunnicliff G
    Pharmacol Toxicol; 1991 Sep; 69(3):149-56. PubMed ID: 1796057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors.
    Khan A; Haleem DJ
    Acta Biol Hung; 2007 Dec; 58(4):345-57. PubMed ID: 18277461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.